{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:27:56Z","timestamp":1765960076454,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-B-109010"],"award-info":[{"award-number":["TSGH-B-109010"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.braindev.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T08:03:05Z","timestamp":1580716985000},"page":"373-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The association between tic medication therapy and psychiatric comorbidities among patients with Tourette syndrome: A national population-based study in Taiwan"],"prefix":"10.1016","volume":"42","author":[{"given":"Chia-Wen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Wei","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hsiang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huei-Shyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Ju","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu-Chien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2020.01.002_b0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DBP.0000000000000065","article-title":"A national profile of Tourette syndrome, 2011\u20132012","volume":"35","author":"Bitsko","year":"2014","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.braindev.2020.01.002_b0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaac.2011.11.004","article-title":"Prevalence of Tourette syndrome and chronic in the population-based Avon longitudinal study of parents and children Cohort","volume":"51","author":"Scharf","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.braindev.2020.01.002_b0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/01.JNR.0000387612.85897.9a","article-title":"Parenting stress and related factors in parents of children with Tourette syndrome","volume":"15","author":"Lee","year":"2007","journal-title":"Nurs Res"},{"key":"10.1016\/j.braindev.2020.01.002_b0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1469-8749.2003.tb00402.x","article-title":"Prevalence of tic disorders and Tourette syndrome in a Swedish school population","volume":"45","author":"Khalifa","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.002_b0025","first-page":"581","article-title":"Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years-United States, 2007","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Wkly Rep"},{"key":"10.1016\/j.braindev.2020.01.002_b0030","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.2010.607","article-title":"Behavior therapy for children with Tourette disorder: a randomized controlled trial","volume":"303","author":"Piacentini","year":"2010","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.braindev.2020.01.002_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/jnp.2009.21.1.13","article-title":"The behavioural spectrum of Gilles de la Tourette syndrome","volume":"21","author":"Cavanna","year":"2009","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.braindev.2020.01.002_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0387-7604(03)90005-2","article-title":"Tourette\u2019s syndrome in Taiwan: an epidemiological study of tic disorders in an elementary school at Taipei County","volume":"25","author":"Wang","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2020.01.002_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-3999(02)00580-9","article-title":"Diagnosing Tourette syndrome: is it a common disorder?","volume":"55","author":"Robertson","year":"2003","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.braindev.2020.01.002_b0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/DBP.0b013e3182829f2b","article-title":"Tourette syndrome and risk of depression: a population-based Cohort study in Taiwan","volume":"34","author":"Chou","year":"2013","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.braindev.2020.01.002_b0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1059840509343113","article-title":"Tourette syndrome: information for school nurses","volume":"26","author":"Golder","year":"2010","journal-title":"J Sch Nurs"},{"key":"10.1016\/j.braindev.2020.01.002_b0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/08830738060210081301","article-title":"Co-occurring psychiatric disorders in children and adolescents with Tourette syndrome","volume":"21","author":"Gaze","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.002_b0065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ncl.2009.04.011","article-title":"Tourette syndrome","volume":"27","author":"Jimenez-Shahed","year":"2009","journal-title":"Neurol Clin"},{"key":"10.1016\/j.braindev.2020.01.002_b0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1469-8749.2000.tb00346.x","article-title":"An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries","volume":"42","author":"Freeman","year":"2000","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.002_b0075","first-page":"1","article-title":"Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey","volume":"4","author":"Liu","year":"2006","journal-title":"J Health Manage"},{"key":"10.1016\/j.braindev.2020.01.002_b0080","first-page":"161","article-title":"Treatment of Tourette syndrome","volume":"11","author":"Kurlan","year":"2014","journal-title":"NeuroRx"},{"key":"10.1016\/j.braindev.2020.01.002_b0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/dmcn.12318","article-title":"Tourette syndrome and chronic tic disorder are associated with lower socio-economic status: findings from the Avon Longitudinal Study of Parents and Children cohort","volume":"56","author":"Miller","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.002_b0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: Pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.braindev.2020.01.002_b0095","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and ADHD","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.braindev.2020.01.002_b0100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","article-title":"Clonidine treatment of Gilles de la Tourette syndrome","volume":"48","author":"Leckman","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.braindev.2020.01.002_b0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/cap.2010.0027","article-title":"An overview of the treatment of Tourette\u2019s Disorder and Tics","volume":"20","author":"Parraga","year":"2010","journal-title":"J Child Adol Psychop"},{"key":"10.1016\/j.braindev.2020.01.002_b0110","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/00004583-199509000-00010","article-title":"Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette\u2019s syndrome: Preliminary clinical experience","volume":"34","author":"Chappell","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.braindev.2020.01.002_b0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1875-9572(10)60050-2","article-title":"Tourette syndrome in children: an updated review","volume":"51","author":"Du","year":"2010","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.braindev.2020.01.002_b0120","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1089\/cap.2015.0104","article-title":"The effectiveness of aripiprazole for tics, social adjustment, and parental stress in children and adolescents with Tourette\u2019s disorder","volume":"26","author":"Wang","year":"2016","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"10.1016\/j.braindev.2020.01.002_b0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jocrd.2014.04.006","article-title":"Pharmacological treatment of Tourette syndrome","volume":"3","author":"Gilbert","year":"2014","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"10.1016\/j.braindev.2020.01.002_b0130","first-page":"57","article-title":"Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders Pediatric","volume":"7","author":"Cox","year":"2016","journal-title":"Health Med Ther"},{"key":"10.1016\/j.braindev.2020.01.002_b0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections\u2014a nationwide, population-based cohort study in Taiwan","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"year":"2013","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","key":"10.1016\/j.braindev.2020.01.002_b0140"},{"key":"10.1016\/j.braindev.2020.01.002_b0145","first-page":"323","article-title":"Emerging treatment for Tourette\u2019s disorder","volume":"10","author":"Bloch","year":"2008","journal-title":"Curr Psychiatry Res"},{"key":"10.1016\/j.braindev.2020.01.002_b0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S2215-0366(14)00133-3","article-title":"A personal 35 year perspective on Gilles de la Tourette syndrome: assessment, investigations, and management","volume":"2","author":"Robertson","year":"2015","journal-title":"Lancet Psychiatry."},{"key":"10.1016\/j.braindev.2020.01.002_b0155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/nedt.2006.2.4.587","article-title":"Uneven focal shoe deterioration in Tourette syndrome","volume":"2","author":"Cavanna","year":"2006","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.braindev.2020.01.002_b0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00004583-199606000-00008","article-title":"Combined pharmacotherapy for TS and OCD","volume":"35","author":"Hawkridge","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.braindev.2020.01.002_b0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/bjp.bp.109.071050","article-title":"Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study","volume":"197","author":"Gorman","year":"2010","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.braindev.2020.01.002_b0170","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/01.chi.0000251210.98749.83","article-title":"Psychopathology in a Swedish population of school children with tic disorders","volume":"45","author":"Khalifa","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.braindev.2020.01.002_b0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejpn.2013.01.005","article-title":"Tourette syndrome and comorbid ADHD: current pharmacological treatment options","volume":"17","author":"Rizzo","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2020.01.002_b0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/archdischild-2011-300585","article-title":"The Gilles De La Tourette syndrome: the current status","volume":"97","author":"Robertson","year":"2012","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.braindev.2020.01.002_b0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.braindev.2009.01.005","article-title":"Association between Tourette syndrome and comorbidities in Japan","volume":"32","author":"Kano","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2020.01.002_b0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mdc3.12428","article-title":"Tics in the pediatric population: pragmatic management","volume":"4","author":"Ganos","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.braindev.2020.01.002_b0195","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11940-010-0095-4","article-title":"Treatment of tics and Tourette syndrome","volume":"12","author":"Singer","year":"2010","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.braindev.2020.01.002_b0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.parkreldis.2017.08.004","article-title":"The colorful spectrum of Tourette syndrome and its medical, surgical and behavioral therapies","volume":"46","author":"Roth","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.braindev.2020.01.002_b0205","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","article-title":"Contemporary assessment and pharmacotherapy of Tourette syndrome","volume":"3","author":"Scahill","year":"2006","journal-title":"NeuroRx"},{"key":"10.1016\/j.braindev.2020.01.002_b0210","first-page":"129","article-title":"Causes of haloperidol discontinuation in patients with Tourette\u2019s disorder: management and alternatives","volume":"57","author":"Silva","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.braindev.2020.01.002_b0215","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/0269881111408462","article-title":"Tolerability profile of aripiprazole in patients with Tourette syndrome","volume":"26","author":"Cavanna","year":"2012","journal-title":"J Psychopharmacol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420300206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420300206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:48:52Z","timestamp":1759952932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760420300206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0387760420300206"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2020.01.002","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between tic medication therapy and psychiatric comorbidities among patients with Tourette syndrome: A national population-based study in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}